Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 82 articles: HTML format

Single Articles

September 2025
1. PAN T, Zhu J, Wang X, Tang D, et al
   MEN1 Promotes Ferroptosis by Disrupting CD44 Alternative Splicing to Suppress Lung Cancer.
   Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-25-0021.
   PubMed     Abstract available
   
   
   
2. GEBRU MT, Hoffman TE, Boudreau A, Vu N, et al
   Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer.
   Cancer Res. 2025 Sep 18. doi: 10.1158/0008-5472.CAN-24-4887.
   PubMed     Abstract available
   
   
   
3. KNOLL N, Masser S, Bordas B, Ebright RY, et al
   CRISPR-Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer.
   Cancer Res. 2025;85:3518-3539.
   PubMed     Abstract available
   
   
   
4. CAO G, Ma L, Wang X, Li G, et al
   Interaction and Reciprocal Stabilization of H3.3 and PARP1 Promotes DNA Damage Repair and Tumor Progression in Small Cell Lung Cancer.
   Cancer Res. 2025 Sep 12. doi: 10.1158/0008-5472.CAN-24-4245.
   PubMed     Abstract available
   
   
   
5. WU CP, Vaishnavi A
   Another Slice of the Pie Uncovered: RIT1M90I Is an Actionable Driver in Non-Small Cell Lung Cancer.
   Cancer Res. 2025;85:3186-3188.
   PubMed     Abstract available
   
   
   
6. MOZZARELLI AM, Cuevas-Navarro A, Shuldiner EG, Vega M, et al
   RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma.
   Cancer Res. 2025;85:3196-3206.
   PubMed     Abstract available
   
   
   
7. DIMARCO AV, Ravichandran M, Lau J, Lima A, et al
   RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted Therapy.
   Cancer Res. 2025;85:3207-3218.
   PubMed     Abstract available
   
   
   August 2025
8. DING W, Zhu J, Mo J, Ouyang S, et al
   Neuropeptide Precursor VGF Promotes Neuroendocrine Differentiation and Cancer-Associated Fibroblast Activation in Small Cell Lung Cancer.
   Cancer Res. 2025 Aug 26. doi: 10.1158/0008-5472.CAN-25-0405.
   PubMed     Abstract available
   
   
   
9. ZHAO J, Zhang W, Zeng Y, Lu D, et al
   Targeting ATP7A-Dependent Copper Metabolic Homeostasis Induces Cuproptosis and Suppresses the Progression of Mutant KRAS-Driven Lung Cancer.
   Cancer Res. 2025 Aug 21. doi: 10.1158/0008-5472.CAN-24-2558.
   PubMed     Abstract available
   
   
   
10. QIN N, Wang Z, Xu X, Xie Y, et al
    Comprehensive Characterization of Somatic Mutation Timing Reveals the Evolutionary Trajectory of Lung Adenocarcinoma in Chinese Patients.
    Cancer Res. 2025;85:2905-2920.
    PubMed     Abstract available
    
    
    July 2025
11. REDIN E, Otegui N, Santos M, Leon S, et al
    Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy.
    Cancer Res. 2025 Jul 25. doi: 10.1158/0008-5472.CAN-24-2772.
    PubMed     Abstract available
    
    
    
12. SEN U, Coleman C, Gandhi N, Jethalia V, et al
    SCD1 Inhibition Blocks the AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma.
    Cancer Res. 2025;85:2485-2503.
    PubMed     Abstract available
    
    
    June 2025
13. WANG Y, Meraz IM, Qudratullah M, Kotagiri S, et al
    Mutation of SMARCA4 Induces Cancer Cell-Intrinsic Defects in the Enhancer Landscape and Resistance to Immunotherapy.
    Cancer Res. 2025;85:1997-2013.
    PubMed     Abstract available
    
    
    May 2025
14. TONG X, Lin G, Ji H
    "Dr. Jekyll and Mr. Hyde": AT2 Cells in Lung Regeneration and Tumor Development.
    Cancer Res. 2025;85:1753-1754.
    PubMed     Abstract available
    
    
    
15. WANG K, Li J, Zhang H, Ma H, et al
    Tobacco Smoking Rewires Cell Metabolism by Inducing GAPDH Succinylation to Promote Lung Cancer Progression.
    Cancer Res. 2025 May 14. doi: 10.1158/0008-5472.CAN-24-3525.
    PubMed     Abstract available
    
    
    
16. QU T, Song L, Xu J, Lu X, et al
    MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer.
    Cancer Res. 2025 May 14. doi: 10.1158/0008-5472.CAN-23-3748.
    PubMed     Abstract available
    
    
    
17. THOMAS-JARDIN S, Suresh S, Arce A, Novaresi N, et al
    The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung Cancer.
    Cancer Res. 2025 May 6. doi: 10.1158/0008-5472.CAN-24-3844.
    PubMed     Abstract available
    
    
    
18. PAPARGYRIOU A, Reichert M
    The Biology in the Pattern: Metastatic Organotropism and Clinical Outcome Depend on DNA Damage Response and Immune Interactions in Pancreatic Cancer.
    Cancer Res. 2025;85:1571-1573.
    PubMed     Abstract available
    
    
    
19. HAN J, Du J, Li X, Zhou Q, et al
    The Glycosyltransferase XYLT1 Activates NF-kappaB Signaling to Promote Metastasis of Early-Stage Lung Adenocarcinoma.
    Cancer Res. 2025;85:1628-1643.
    PubMed     Abstract available
    
    
    April 2025
20. CAI L, Wu F, Zhou Q, Gao Y, et al
    The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.
    Cancer Res. 2025 Apr 29:OF1-OF15. doi: 10.1158/0008-5472.CAN-24-1607.
    PubMed     Abstract available
    
    
    
21. LIU C, Du H, Yu G, Qi J, et al
    Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression.
    Cancer Res. 2025 Apr 9. doi: 10.1158/0008-5472.CAN-24-3481.
    PubMed     Abstract available
    
    
    
22. EIGENBROOD J, Wong N, Mallory P, Pereira JS, et al
    Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases.
    Cancer Res. 2025 Apr 2. doi: 10.1158/0008-5472.CAN-24-3723.
    PubMed     Abstract available
    
    
    March 2025
23. LEE TR, Ahn JM, Lee J, Kim D, et al
    Integrating Plasma Cell-Free DNA Fragment End Motif and Size with Genomic Features Enables Lung Cancer Detection.
    Cancer Res. 2025 Mar 26:OF1-OF12. doi: 10.1158/0008-5472.CAN-24-1517.
    PubMed     Abstract available
    
    
    
24. SCORTEGAGNA M, Murad R, Bina P, Feng Y, et al
    Age-Associated Modulation of TREM1/2-Expressing Macrophages Promotes Melanoma Progression and Metastasis.
    Cancer Res. 2025 Mar 24. doi: 10.1158/0008-5472.CAN-24-4317.
    PubMed     Abstract available
    
    
    
25. SOS ML, Koker M, Weir BA, Heynck S, et al
    Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.
    Cancer Res. 2025;85:1003.
    PubMed    
    
    
    February 2025
26. BADO IL
    Deterministic Role of FOXF2 in Organ-Specific Macrometastasis Transition.
    Cancer Res. 2025;85:639-641.
    PubMed     Abstract available
    
    
    
27. CHEN YC, Hsu CL, Wang HM, Wu SG, et al
    Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-Smokers.
    Cancer Res. 2025;85:602-617.
    PubMed     Abstract available
    
    
    
28. ZHANG Y, Song X, Feng Y, Qian Y, et al
    The circRNA cEMSY Induces Immunogenic Cell Death and Boosts Immunotherapy Efficacy in Lung Adenocarcinoma.
    Cancer Res. 2025;85:497-514.
    PubMed     Abstract available
    
    
    January 2025
29. DALEY BR, Sealover NE, Finniff BA, Hughes JM, et al
    SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma.
    Cancer Res. 2025;85:118-133.
    PubMed     Abstract available
    
    
    December 2024
30. CHEN SY, He PL, Lu LY, Lin MC, et al
    ST6GAL1-Mediated Sialylation of PECAM-1 Promotes a Transcellular Diapedesis-Like Process that Directs Lung Tropism of Metastatic Breast Cancer.
    Cancer Res. 2024 Dec 30. doi: 10.1158/0008-5472.CAN-24-1550.
    PubMed     Abstract available
    
    
    
31. SAAL J, Klumper N, Holzel M
    C-Reactive Protein Facilitates Premetastatic Niche Formation in the Lungs.
    Cancer Res. 2024;84:4121-4123.
    PubMed     Abstract available
    
    
    
32. FENG JR, Li X, Han C, Chang Y, et al
    C-Reactive Protein Induces Immunosuppression by Activating FcgammaR2B in Pulmonary Macrophages to Promote Lung Metastasis.
    Cancer Res. 2024;84:4184-4198.
    PubMed     Abstract available
    
    
    November 2024
33. JIANG WJ, Zhou TH, Huang HJ, Li LS, et al
    Breast Cancer Subtype-Specific Organotropism is Dictated by FOXF2-Regulated Metastatic Dormancy and Recovery.
    Cancer Res. 2024 Nov 26. doi: 10.1158/0008-5472.CAN-24-0479.
    PubMed     Abstract available
    
    
    
34. WANG S, Lai JC, Li Y, Tang C, et al
    Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR Mutant Non-Small Cell Lung Cancer.
    Cancer Res. 2024 Nov 8. doi: 10.1158/0008-5472.CAN-24-1817.
    PubMed     Abstract available
    
    
    October 2024
35. XU H, Yue M, Zhou R, Wang P, et al
    A Prime-Boost Vaccination Approach Induces Lung Resident Memory CD8+ T Cells Derived from Central Memory T Cells That Prevent Tumor Lung Metastasis.
    Cancer Res. 2024;84:3173-3188.
    PubMed     Abstract available
    
    
    September 2024
36. MAY L, Hu B, Jerajani P, Jagdeesh A, et al
    The Innate Immune System and TRAIL-BCL-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females.
    Cancer Res. 2024 Sep 23. doi: 10.1158/0008-5472.CAN-24-0585.
    PubMed     Abstract available
    
    
    
37. SMITH MR, Dixon CB, Wang Y, Liu Y, et al
    Targeting NTRK1 Enhances Immune Checkpoint Inhibitor Efficacy in NTRK1 Wild-type Non-Small Cell Lung Cancer.
    Cancer Res. 2024 Sep 9. doi: 10.1158/0008-5472.CAN-24-0658.
    PubMed     Abstract available
    
    
    
38. CONNER SJ, Borges HB, Guarin JR, Gerton TJ, et al
    Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis.
    Cancer Res. 2024;84:2761-2775.
    PubMed     Abstract available
    
    
    August 2024
39. KOO J, Seong CS, Parker RE, Herrera A, et al
    Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer.
    Cancer Res. 2024 Aug 29. doi: 10.1158/0008-5472.CAN-23-2631.
    PubMed     Abstract available
    
    
    
40. LIN W, Wang N, Wu S, Diao M, et al
    NUAK1-Mediated Phosphorylation of NADK Mitigates ROS Accumulation to Promote Osimertinib Resistance in Non-Small Cell Lung Carcinoma.
    Cancer Res. 2024 Aug 19. doi: 10.1158/0008-5472.CAN-24-0249.
    PubMed     Abstract available
    
    
    
41. ZHANG C, Zhou L, Zhang M, Du Y, et al
    H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer.
    Cancer Res. 2024 Aug 13. doi: 10.1158/0008-5472.CAN-23-3513.
    PubMed     Abstract available
    
    
    
42. FU M, Gao Q, Xiao M, Li RF, et al
    Extracellular Vesicles Containing circMYBL1 Induce CD44 in Adenoid Cystic Carcinoma Cells and Pulmonary Endothelial Cells to Promote Lung Metastasis.
    Cancer Res. 2024;84:2484-2500.
    PubMed     Abstract available
    
    
    July 2024
43. WANG X, Qu Y, Xu Q, Jiang Z, et al
    NQO1 Triggers Neutrophil Recruitment and NET formation to Drive Lung Metastasis of Invasive Breast Cancer.
    Cancer Res. 2024 Jul 29. doi: 10.1158/0008-5472.CAN-24-0291.
    PubMed     Abstract available
    
    
    
44. LI J, Luo L, He J, Yu J, et al
    A Virus-Inspired Inhalable Liponanogel Induces Potent Antitumor Immunity and Regression in Metastatic Lung Tumors.
    Cancer Res. 2024;84:2352-2363.
    PubMed     Abstract available
    
    
    June 2024
45. OATMAN N, Gawali MV, Congrove S, Caceres R, et al
    A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis.
    Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-23-1635.
    PubMed     Abstract available
    
    
    
46. HUANG CY, Jiang N, Shen M, Lai GG, et al
    Oncogene-Driven Non-Small Cell Lung Cancers in Patients with a History of Smoking Lack Smoking-Induced Mutations.
    Cancer Res. 2024;84:2009-2020.
    PubMed     Abstract available
    
    
    
47. HERZOG C, Jones A, Evans I, Raut JR, et al
    Cigarette Smoking and E-cigarette Use Induce Shared DNA Methylation Changes Linked to Carcinogenesis.
    Cancer Res. 2024;84:1898-1914.
    PubMed     Abstract available
    
    
    May 2024
48. RAINERO E
    Overcoming Nutrient Stress: Integrin alphavbeta3-Driven Metabolic Adaptation Supports Tumor Initiation.
    Cancer Res. 2024;84:1543-1545.
    PubMed     Abstract available
    
    
    
49. PARK SJ, Ju S, Goh SH, Yoon BH, et al
    Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
    Cancer Res. 2024;84:1491-1503.
    PubMed     Abstract available
    
    
    
50. XIANG H, Pan Y, Sze MA, Wlodarska M, et al
    Single-Cell Analysis Identifies NOTCH3-Mediated Interactions between Stromal Cells That Promote Microenvironment Remodeling and Invasion in Lung Adenocarcinoma.
    Cancer Res. 2024;84:1410-1425.
    PubMed     Abstract available
    
    
    April 2024
51. BOUMELHA J, de Castro A, Bah N, Cha H, et al
    CRISPR-Cas9 screening identifies KRAS-induced COX-2 as a driver of immunotherapy resistance in lung cancer.
    Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2627.
    PubMed     Abstract available
    
    
    
52. RUMDE PH, Burns TF
    A Path to Persistence after EGFR Inhibition.
    Cancer Res. 2024;84:1188-1190.
    PubMed     Abstract available
    
    
    
53. PETRONI G, Pillozzi S, Antonuzzo L
    Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy.
    Cancer Res. 2024;84:1199-1209.
    PubMed     Abstract available
    
    
    
54. LAU A, Blenis J, Burgos-Barragan G
    Decoding Serine Metabolism: Unveiling Novel Pathways for Evolving Cancer Therapies.
    Cancer Res. 2024;84:1191-1194.
    PubMed     Abstract available
    
    
    
55. ZHU X, Fu Z, Dutchak K, Arabzadeh A, et al
    Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer.
    Cancer Res. 2024;84:1333-1351.
    PubMed     Abstract available
    
    
    
56. NAM A, Jain S, Wu C, Campos A, et al
    Integrin alphavbeta3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity.
    Cancer Res. 2024 Apr 8:OF1-OF13. doi: 10.1158/0008-5472.CAN-23-2700.
    PubMed     Abstract available
    
    
    
57. LIU Y, Murazzi I, Fuller AM, Pan H, et al
    Sarcoma Cells Secrete Hypoxia-Modified Collagen VI to Weaken the Lung Endothelial Barrier and Promote Metastasis.
    Cancer Res. 2024;84:977-993.
    PubMed     Abstract available
    
    
    
58. XU Y, Deng C, Chen H, Song Y, et al
    Osteosarcoma Cells Secrete CXCL14 That Activates Integrin alpha11beta1 on Fibroblasts to Form a Lung Metastatic Niche.
    Cancer Res. 2024;84:994-1012.
    PubMed     Abstract available
    
    
    March 2024
59. GAI X, Liu Y, Lan X, Chen L, et al
    Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer.
    Cancer Res. 2024 Mar 19. doi: 10.1158/0008-5472.CAN-23-2095.
    PubMed     Abstract available
    
    
    
60. WANG H, Zhang Y, Tian Y, Yang W, et al
    DNA-PK-Mediated Cytoplasmic DNA Sensing Stimulates Glycolysis to Promote Lung Squamous Cell Carcinoma Malignancy and Chemoresistance.
    Cancer Res. 2024;84:688-702.
    PubMed     Abstract available
    
    
    February 2024
61. HU B, Wiesehofer M, de Miguel FJ, Liu Z, et al
    ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
    Cancer Res. 2024 Feb 15. doi: 10.1158/0008-5472.CAN-23-0438.
    PubMed     Abstract available
    
    
    
62. ALEWINE C
    Macrophages Under the Influence of Tumor Mesothelin Weaken Host Defenses against Pancreatic Cancer Metastasis.
    Cancer Res. 2024;84:513-514.
    PubMed     Abstract available
    
    
    
63. RIGAMONTI A, Viatore M, Polidori R, Rahal D, et al
    Integrating AI-powered digital pathology and imaging mass cytometry identifies key classifiers of tumor cells, stroma, and immune cells in non-small cell lung cancer.
    Cancer Res. 2024 Feb 5. doi: 10.1158/0008-5472.CAN-23-1698.
    PubMed     Abstract available
    
    
    January 2024
64. MU M, Huang CX, Qu C, Li PL, et al
    Targeting ferroptosis-elicited inflammation suppresses hepatocellular carcinoma metastasis and enhances sorafenib efficacy.
    Cancer Res. 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1796.
    PubMed     Abstract available
    
    
    
65. SAGGESE P, Pandey A, Alcaraz M Jr, Fung E, et al
    Glucose Deprivation Promotes Pseudohypoxia and Dedifferentiation in Lung Adenocarcinoma.
    Cancer Res. 2024;84:305-327.
    PubMed     Abstract available
    
    
    December 2023
66. NIU X, Martinez L
    Harnessing p53 to Improve Immunotherapy for Lung Cancer Treatment.
    Cancer Res. 2023 Dec 21:OF1-OF2. doi: 10.1158/0008-5472.CAN-23-3929.
    PubMed     Abstract available
    
    
    
67. DU M, Xin J, Zheng R, Yuan Q, et al
    CYP2A6 activity and cigarette consumption interact in smoking-related lung cancer susceptibility.
    Cancer Res. 2023 Dec 20. doi: 10.1158/0008-5472.CAN-23-0900.
    PubMed     Abstract available
    
    
    
68. MUKHOPADHYAY S, Huang HY, Lin Z, Ranieri M, et al
    Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
    Cancer Res. 2023;83:4095-4111.
    PubMed     Abstract available
    
    
    
69. NIU X, Martinez L
    Harnessing p53 to improve immunotherapy for lung cancer treatment.
    Cancer Res. 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-3929.
    PubMed     Abstract available
    
    
    
70. XIA L, Liu JY, Yang MY, Zhang XH, et al
    Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells.
    Cancer Res. 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-1632.
    PubMed     Abstract available
    
    
    
71. MICHAUD DE, Guerriero JL
    Myeloid cells pave the metastatic road in breast cancer.
    Cancer Res. 2023 Dec 6. doi: 10.1158/0008-5472.CAN-23-3803.
    PubMed     Abstract available
    
    
    November 2023
72. KO JH, Lambert KE, Bhattacharya D, Lee MC, et al
    Small cell lung cancer plasticity enables NFIB-independent metastasis.
    Cancer Res. 2023 Nov 14. doi: 10.1158/0008-5472.CAN-23-1079.
    PubMed     Abstract available
    
    
    
73. PRAHALLAD A, Weiss A, Voshol H, Kerr G, et al
    CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer.
    Cancer Res. 2023 Nov 7. doi: 10.1158/0008-5472.CAN-23-1127.
    PubMed     Abstract available
    
    
    
74. WEBER MC, Izzo LT, Oliver TG
    Epigenetic Regulators Open the Door to SCLC Plasticity.
    Cancer Res. 2023;83:3495-3497.
    PubMed     Abstract available
    
    
    
75. COTTON JL, Estrada Diez J, Sagar V, Chen J, et al
    Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance.
    Cancer Res. 2023;83:3611-3623.
    PubMed     Abstract available
    
    
    October 2023
76. HARIPRAKASH JM, Salviato E, La Mastra F, Sebestyen E, et al
    Leveraging tissue-specific enhancer-target gene regulatory networks identifies enhancer somatic mutations that functionally impact lung cancer.
    Cancer Res. 2023 Oct 19. doi: 10.1158/0008-5472.CAN-23-1129.
    PubMed     Abstract available
    
    
    
77. WU J, Subbiah V
    RETooling the RET Inhibitor Pralsetinib for ESR1 Fusion-Positive Breast Cancer and Beyond.
    Cancer Res. 2023;83:3159-3161.
    PubMed     Abstract available
    
    
    
78. YANAGAWA J, Tran LM, Salehi-Rad R, Lim RJ, et al
    Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma.
    Cancer Res. 2023;83:3305-3319.
    PubMed     Abstract available
    
    
    
79. NAMBIAR DK, Viswanathan V, Cao H, Zhang W, et al
    Galectin-1 Mediates Chronic STING Activation in Tumors to Promote Metastasis through MDSC Recruitment.
    Cancer Res. 2023;83:3205-3219.
    PubMed     Abstract available
    
    
    August 2023
80. COHEN N, Mundhe D, Deasy SK, Adler O, et al
    Breast cancer-secreted factors promote lung metastasis by signaling systemically to induce a fibrotic pre-metastatic niche.
    Cancer Res. 2023 Aug 7:CAN-22-3707. doi: 10.1158/0008-5472.CAN-22-3707.
    PubMed     Abstract available
    
    
    
81. MATHUR D, Liao C, Lin W, La Ferlita A, et al
    The ratio of key metabolic transcripts is a predictive biomarker of breast cancer metastasis to the lung.
    Cancer Res. 2023 Aug 1:CAN-23-0153. doi: 10.1158/0008-5472.CAN-23-0153.
    PubMed     Abstract available
    
    
    July 2023
82. KA NL, Park MK, Kim SS, Jeon Y, et al
    NR1D1 stimulates antitumor immune responses in breast cancer by activating cGAS-STING signaling.
    Cancer Res. 2023 Jul 3:CAN-23-0329. doi: 10.1158/0008-5472.CAN-23-0329.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.